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Reagent Clone Dilution Isotype Source 
BCL6 IG191E/A8 1:300 mIgG1 kindly provided by G. Roncador 
(Centro Nacional de Investigaciones 
Oncológicas Madrid, Spain) 
CD1a 010 1:50 mIgG1 Dako 
CD3 SP7 1:100 rabbit Thermo Scientific, Waltham, MA 
CD4 4B12 1:40 mIgG1 Thermo Scientific 
CD8 C8/144B 1:30 mIgG1 Dako 
CD11b  1:300 rabbit polyclonal Sigma-Aldrich 
CD14 7 1:50 mIgG2a 
Novocastra Laboratories,  
Newcastle upon Tyne, United 
Kingdom 
CD66b G10F5 1:200 mIgM BioLegend,  San Diego, CA 
CD83 1H4b 1:150 mIgG1 Novocastra Laboratories 
DD1 DD1 1:60 mIgM kindly provided by Knut Schäkel 




MNF116 1:100 mIgG1 Dako 
Ki-67 MM1 1:100 mIgG1 Novocastra Laboratories  
Supplementary Table S2. List of the antibodies used for flow cytometry.  
Antibody  Clone  Isotype  Source  
AlexaFluor488 anti-human CD1c L161 mIgG1 BioLegend 
AlexaFluor647 anti-human CX3CR1  2A9-1  rat IgG2b  BioLegend  
AlexaFluor647 rat IgG2b  RTK4530   BioLegend  
APC anti-human CD11b ICRF44 mIgG1 BioLegend 
APC anti-human CD11c  MJ4-27G12  mIgG2b  Miltenyi Biotec 
APC anti-human CD14 TUK4  mIgG2a  Miltenyi Biotec 
APC anti-human CD141 (BDCA-3)  AD5-14H12  mIgG1  Miltenyi Biotec 
APC-Cy7 anti-human HLA-DR  L243  mIgG2a  BioLegend  
Brilliant Violet 510 anti-human CD45  HI30  mIgG1  BioLegend  
FITC anti-human CD14 TÜK4 mIgG2a Miltenyi Biotec 
FITC anti-human CD141  AD5-14H12 mIgG1 Miltenyi Biotec 
FITC anti-human CD303  AC144  mIgG1  Miltenyi Biotec  
FITC anti-human Slan (M-DC8)  DD1  mIgM  Miltenyi Biotec 
PE anti-human CD1c (BDCA-1)  AD5-8E7  mIgG2a  Miltenyi Biotec 
PE anti-human CD11b ICRF44 mIgG1 BioLegend 
PE anti-human CD115 9-4D2-1E4 rat IgG1 BioLegend 
PE anti-human CD14 TUK4  mIgG2a  Miltenyi Biotec 
PE anti-human CD16 3G8  mIgG1  BioLegend  
PE anti-human CD163 GHI/61 mIgG1 BioLegend 
PE anti-human CD40 HB14 mIgG1 BioLegend 
PE anti-human CD80 2D10 mIgG1 BioLegend 
PE anti-human CD83 HB15 mIgG1 Miltenyi Biotec 
PE anti-human CD86 IT2.2 mIgG2b BioLegend 
PE anti-human FcRI CRA1 mIgG2b Miltenyi Biotec 
PE anti-human CD206 15-2 mIgG1 BioLegend 
PE anti-human CD209 (DC-SIGN) 9E9A8 mIgG2a BioLegend 
PE mouse IgG1  MOPC-21  mIgG1 BioLegend  
PE-Cy7 anti-human CD19  HIB19  mIgG1  BioLegend  
PE-Cy7 anti-human CD3  UCHT1  mIgG1  BioLegend  
PerCP-Cy5.5 anti-human CD16  3G8  mIgG1  BioLegend  















 monocytes/macrophages in human tonsils.  











 monocytes/macrophages. Steps 1-4 were sequentially used to 
exclude cell debris (1), doublets (2), dead cells (3), and, ultimately, to gate CD45
+
 leukocytes (4). Subsequently, 
in steps 5-7, analysis was performed on CD3/CD19-negative cells (5). Within the latter cells, HLA-DR-positive 









includes, in fact, all myeloid DCs, macrophages and monocytes. Steps 8-11 show the specific combination of 
markers used to gate each myeloid population type: slan/M-DC8
+
 DCs (purple gate, 8), CD1c
+
 DCs (green gate, 
9), CD141
+

















Supplementary Figure S2. TNFandIL-12p70 secretion by tonsil slan/M-DC8+ DCs. 
Tonsil cell suspensions were incubated with or without 100 U ml
-1
 IFNplus either 100 ng ml-1 LPS or 5 M 
R848, either for 4 h (to detect TNF secretion), or for 12 h, after a 6 h pre-incubation (to detect IL-12p70 
secretion). Contour plots display a representative experiment illustrating the percentage of TNF- (a) or IL-
12p70- (b) secreting tonsil slan/M-DC8
+
 DCs. 
 
